Merrimack Pharmaceuticals, Inc.
ANTI-TNFR2 ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
Anti-TNFR2 antibodies which bind to particular human TNFR2 epitopes, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer are disclosed.
Status:
Application
Type:
Utility
Filling date:
18 Sep 2019
Issue date:
2 Dec 2021